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Abstract
Investigation of possible adverse health effects of nanomaterials, in a rapid multi-parametric
fashion, has become increasingly important, due to their increased production and potential
uses in a wide range of application areas, from cosmetics to pharmaceutics. Although
conventional in-vitro cytotoxicological techniques provide valuable information about the
particle toxicity, the importance of gaining high content information in a single assay with the
analysis of multiple parameters in a non-invasive and label-free way is still one of the biggest
challenges in nanotoxicology. As a vibrational spectroscopic technique, the power of Raman
spectroscopy for the analysis of cells, tissues and also nanoparticle localization within cells
has been shown previously. In this study, the ability of Raman spectroscopy to fingerprint the
dose and time dependent cellular responses and effect of cytotoxic events on biochemical
constituents of the cells is monitored. A549 human lung carcinoma cells and aminated
polystyrene nanoparticles (PS-NH2) are used as a model cell line and nanoparticle,
respectively. Following the determination of cellular responses in the presence of toxic PSNH2 by using conventional cellular assays, Alamar Blue (AB) and (3-(4,5-Dimethylthiazol-2-

yl)-2,5diphenyltetrazoliumbromid (MTT), and calculation of EC50 values for both assays,
Raman spectroscopy was employed at response related doses and time points. Multiple point
spectra from the cytoplasm, nucleus and nucleolus of 20 cells were acquired using Raman
spectroscopy for each exposure dose and timepoint. Unsupervised principle components
analysis (PCA) was applied to the Raman data sets for the comparison of exposed and
unexposed cells as well as different exposure doses and times. The study shows the ability of
Raman spectroscopy to provide information about cellular responses at different particle
concentrations and exposure times with the aid of multivariate analysis. In the chosen range
of concentrations, the most significant changes were observed in the cytoplasm for both time
dependent and dose dependent cases due to the route of endocytosis The Raman spectral
markers for lipidosis, ROS formation and oxidative stress related biochemical damage are
determined and correlated with exposure dose and time, and the responses are correlated with
conventional cytotoxicity assays.

Keywords: Nanotoxicology, Raman spectroscopy, aminated polystyrene nanoparticles, in
vitro screening, dose-dependent toxicity, time-dependent toxicity, Label free imaging

Introduction
The growing interest and research in nanoscience and nanotechnology has introduced a
plethora of nanomaterials into human life. More than 1600 products of nanotechnology have
already found their place in the market, ranging from cosmetics to pharmaceutics (more
information

about

nanotechnology

based

products

can

be

found

at

http://www.nanotechproject.org/)1. From their production, to use and disposal by consumers,
nanomaterials interact with living systems and the environment via different exposure routes.
Due to their size, different surface properties and reactivity, related to their physicochemical
properties, these novel materials can easily interact with biological systems. The emergence
of Nanoscience and Nanotechnology has therefore given rise to the fields of Nanotoxicology2
and Nanomedicine3. Nanotoxicology mainly deals with the possible adverse biological
effects of nanomaterials for humans and ultimately the environment4. The Organisation for
Economic Co-operation and Development (OECD) recommends established and commonly
used protocols for nanotoxicological assessment5, such as cell viability tests (3-(4,5Dimethylthiazol-2-yl)-2,5diphenyltetrazoliumbromid (MTT), Neutral Red (NR) and Alamar
Blue (AB)). On the other hand, Nanomedicine promises new paradigms in targeted drug
delivery, diagnostics and imaging6,7. However, direct visualisation of the nanomaterials
within cells, and the resultant cellular responses remains a challenge.
Raman spectroscopy has origin in inelastic collision of photons with molecules and provides
fingerprint information about the specimen under investigation8,9. Due to the nature of the
technique, fingerprint information at a molecular level, easy sample preparation steps, narrow
spectral bandwidth and minimal influence from the water, a natural component of biological
samples, the technique has attracted interest for the analysis of biological structures. The
applicability of Raman spectroscopy as a tool for analysis of cells, tissues and biofluids has
been demonstrated in recent years10-15. The technique has also been widely used for the

analysis of cell-drug and cell-nanoparticle interactions at a sub-cellular level16-23. The study
of Dorney et al. demonstrated the ability of Raman spectroscopy to identify and discriminate
different subcellular regions as well as the presence of the nanoparticles within these
regions14. Moreover, the study of Keating et al. demonstrated the importance of multivariate
analysis techniques on huge Raman data sets to gain further information about cellnanoparticle localisation24. Also, the ability of the Raman spectroscopy to differentiate
different cellular compartments, such as endosomes and lysosomes, as well as localisation of
the nanoparticles in these compartments has been demonstrated15. For the case of Carbon
Nanotubes, Knief et al.25 probed the correlation of Raman biospectroscopic markers with
conventional cytotoxicity assays, indicating that Raman spectroscopy can potentially be
employed as a single, label free assay to localise nanoparticles, identify trafficking
mechanisms and evaluate nanoparticle toxicity. However, an extensive study of dose and
time dependent cellular responses to nanoparticle exposure has not as yet been reported.
The toxicity of aminated PSNPs (PS-NH2) has been extensively studied by different research
groups to determine the mode of interaction of these nanoparticles with different types of
human cell lines by using conventional cytotoxic and microscopic techniques26-31.
Polystyrene nanoparticles are taken up by most of the cell lines through endocytosis, which is
accepted as the primary mechanism for nanomaterial uptake into the cells32. Basically,
particles are taken up across the cell membrane by the formation of early endosomes which
carry the nanoparticles to the lysosomes. After particles are engulfed by lysosomes, they are
carried to the endoplasmic reticulum15,33,34. In the case of PS-NH2, exposure of cells to the
nanoparticles can induce toxicity due to the formation of Reactive oxygen species (ROS).
The formation of ROS starts with the endocytosis of nanoparticles and continues throughout
their trafficking within cells. The resultant oxidative stress causes the release of inflammatory
factors and triggers apoptosis. Also, release of cationic nanoparticles into the cytosol due to

endosomal or lysosomal rupture resulting from membrane damage allows nanoparticles to
reach the mitochondria and cause a change in mitochondrial membrane potential, also
initiating the apoptotic process29. Aminated polystyrene particles induce cytotoxicity by
triggering caspase mediated apoptotic pathways, even at low exposure doses, due to their
cationic properties. Basically, pro-apoptotic Bcl-2 proteins are located on the mitochondrial
membrane and cause the formation of holes which will release apoptogenic factors and
trigger the caspase activity26,29,30,35. As the responses of cells to commercially available PSNH2 exposure in vitro have been extensively documented, they can serve as ideal model
nanoparticles to explore the capabilities of Raman spectroscopy to monitor cellular responses.
In this study, the dose and time dependent cellular responses and effect of cytotoxic events on
biochemical constituents of the cells are monitored using Raman spectroscopy. Aminated
polystyrene nanoparticles (PS-NH2) are chosen as model nanoparticles due to their welldocumented cytotoxic mechanisms. Human lung adenocarcinoma (A549) cells were chosen
for consistency with other studies15,26, which show common modes of action in a number of
cell lines, and as they act as models for human exposure by inhalation. Cells were exposed to
PS-NH2 in different doses and for different exposure times. In order to determine toxic effects
of the PS-NH2 in A549 cells, the conventional cytotoxic assay, Alamar Blue was carried out
for 4, 8, 12 and 24 hr particle exposure. The 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide (MTT) assay was also used to determine cytotoxic effect of PSNH2 in A549 cells after 8 hr particle exposure to compare the responses from different
cytotoxicity assays. A549 cells were exposed to 2.5, 5 and 10 μM concentrations of the PSNH2 for the evaluation of spectroscopic signatures of the dose-dependent toxic responses in
the fingerprint region of the Raman spectrum. Also, cells were exposed to 2.5 μM of PS-NH2
for 4, 8, 12 and 24 hrs for the assessment of toxicity related changes in biomolecules such as
the proteins, lipids and nucleic acids. In order to elucidate the roles of different cellular

regions and related toxic responses, Raman spectra were acquired from cytoplasm, nucleus
and nucleolus. Raman datasets and unsupervised Principal Component analysis (PCA) was
used for the elucidation and comparison of dose and time dependent biomolecular changes in
the cells upon nanoparticle exposure.

Materials and Methods
Nanoparticles
100 nm amine-modified and fluorescently labelled, latex type, polystyrene nanoparticles (PSNH2, Product Number: L9904) were chosen as model nanoparticles for this study and
purchased from Sigma-Aldrich (Ireland). The peak excitation and emission wavelengths of
the PS-NH2 are specified by the manufacturer as 481 and 644 nm, respectively. The PS-NH2
were further characterised using a Malvern Zetasizer ZS to determine their size and surface
potential in phosphate buffered saline (PBS) and cell culture medium. The nanoparticles were
freshly prepared in pre-warmed cell culture medium containing supplements on the day of
exposure.
Cell Culture
The human lung adenocarcinoma cell line, A549, was purchased from ATCC (ATTC. No:
CCL-185) and cultured in Dulbecco’s Modified Eagle’s Medium Nutrient Mixture F-12
HAM (DMEM-F12) supplemented with 2mM L-glutamine and 10% foetal bovine serum
(FBS, Sigma Aldrich) at 37 oC in a humidified 5% CO2 incubator. Cells were sub-cultured at
three days intervals to 60%-70% confluency.
Preparation of nanoparticle solutions

The PH-NH2 solutions for both Raman measurements and cytotoxicity assays were prepared
to the desired concentrations from initial concentrations by diluting the nanoparticles directly
in 10% FBS and 2mM L-glutamine supplied DMEM-F12.
Cytotoxicity Assays and Determination of half-maximal effective concentration (EC50)
Alamar Blue (AB) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assays were used to evaluate dose and time dependent cytotoxicity responses of 100 nm PSNH2 in A549 cells. AB and MTT assays were purchased from Biosciences Ltd(IRL) and
Sigma-Aldrich (Dublin, Ireland), respectively and both assays were carried out on the same
96-well plate (Nunc, Denmark) by following manufacturer’s instructions. A549 cells were
seeded onto 96-well plates with densities of 1x105 cells/mL and incubated at 37 oC in 5%
CO2 for 24 hrs for initial attachment and to achieve the desired confluency. PS-NH2 solutions
were prepared in the concentration range from 40 to 0.3125 μM by serial dilutions in prewarmed DMEM-F12 medium supplemented with 10% FBS and 2mM L-glutamine.
Following 24 hr initial attachment, the medium was removed and cells were rinsed with 100
μl/well PBS. A549 cells were exposed to the range of PS-NH2 concentrations for each of the
time points, 4, 8, 12, 24 and 48 hr. 10% Dimethyl sulfoxide (DMSO), prepared in cell culture
medium, was used as a positive control. Six replicates of each different nanoparticle
concentration, negative (A549 cells) and positive (DMSO) controls were used in each 96well plate and 3 independent experiments were used to evaluate cytotoxic response of the PSNH2 on A549 cells for both assays. After particle exposures, the cell medium containing
nanoparticles was removed and cells were washed with PBS three times. AB/MTT solution
was prepared in the ratio of 5% [v/v] solution of AB and 10% [v/v] of MTT dye in unsupplemented DMEM-F12. A 100 μl/well of MTT/AB solution was added to A549 cells and
they were incubated for 3 hrs at 37 oC in 5% CO2. A microplate reader (SpectraMax-M3,
Molecular Devices, USA) was used to measure AB fluorescence emission at 595 nm

(excitation/emission 540/595 nm, respectively). Following AB measurement, the cell medium
containing AB and MTT is removed and cells were rinsed with PBS. 100 μl/well of DMSO
were added to the 96-well plates and plates were agitated at 200 rpm for 10 mins. MTT
absorbance was measured at 570 nm by using same plate reader system. The EC50 calculation
was made by using a four parameter sigmoidal fit in SigmaPlot.
Raman Spectroscopy
Raman spectroscopy was used to monitor dose and time dependent changes of cellular
constituents of A549 cells upon PS-NH2 exposure. Approximately ~16000 cells per substrate
were seeded onto CaF2 disks and incubated for 24 hrs at 37 oC in 5% CO2 for initial
attachment. After initial attachment of the cells, cell medium was removed and cells were
rinsed with PBS. The cell medium of A549 cells, which were used as control and will be
referred to as unexposed cells throughout the study, was replaced with fresh 10% FBS and
2mM L-glutamine supplemented DMEM-F12. For the preparation of exposed cells, PS-NH2
solutions with concentrations of 2.5, 5 and 10 μM were prepared in FBS and L-glutamine
supplemented DMEM-F12 for the evaluation of dose dependent responses. A549 cells were
exposed to the each concentration of PS-NH2 for 8 hrs. Exposures to 2.5 μM PS-NH2 were
used for the assessment of time-dependent cellular responses, at 4, 8, 12, 24 and 48 hrs. In
parallel, unexposed cells were incubated in fresh medium at 37 oC in 5% CO2 for periods
equivalent to the PS-NH2 exposure times. Following the particle exposures and incubation of
unexposed cells, medium containing PS-NH2 for exposed cells and cell medium for
unexposed cells was removed and cells were washed with PBS thrice. 10% formalin was
used to fix cells for 10 mins. After fixation of cells, formalin was removed and cells were
washed three times with distilled and sterilised water. Throughout the study, Raman
measurements were acquired by using water-immersion objective. Therefore, after fixation
and washing steps, cells were kept in water and spectra were acquired in water.

A Horiba Jobin-Yvon LabRAM HR800 spectrometer, equipped with a 785 nm diode laser as
source was used throughout the study. All measurements were acquired in water by using a
x100 water immersion objective (LUMPlanF1, Olympus, N.A. 1). The spectrometer was
calibrated to the 520.7 cm-1 line of silicon prior to spectral acquisition. A 300 lines per mm
grating was chosen, which provides approximately 1.5 cm-1 per pixel spectral dispersion. A
100 μm confocal pinhole was used for all measurements. The spectra were dispersed onto a
16 bit dynamic range Peltier cooled CCD detector. Point spectra from the cytoplasm, nucleus
and nucleolus of 20 cells were acquired for each dose and exposure time. The spectral range
from 400 to 1800 cm-1, the so-called fingerprint region, was chosen and spectra were
acquired for 2x30 seconds at each spot. Unexposed cells were used as control for
comparisons of the different doses and exposure times.
Data Analysis
Raman data sets were transferred to Matlab (Mathworks, USA) for data analysis. Preprocessing was carried out in the same data analysis platform to improve spectral quality. For
pre-processing, first, a mild smoothing was applied to data sets by using Savitsky-Golay filter
(3rd order and 9 points). Classical Least Squares (CLS) analysis was employed to minimize
contributions from the background which is dominantly water in the immersion geometry12,36.
Spectra were vector normalized following smoothing and background subtraction. Principle
Component Analysis (PCA) was applied to pre-processed Raman data sets to differentiate the
spectral changes in fingerprint region of the nucleus, nucleolus and cytoplasm upon PS-NH2
exposure.

Results and Discussion
The well-established and commonly used cytotoxicity assay, AB, was carried out to
determine the dose and time dependent toxic effect of PS-NH2 on A549 cells37-39. Figure 1.I
shows the plots of cytotoxic response of PS-NH2 on A549 cells determined by the AB assay.
Half-maximal concentration for cellular viability, EC50, values relating to the different
particle exposure times were calculated in SigmaPlot by a four parameter sigmoidal fit. For 4
hr PS-NH2 exposure, the EC50 value was calculated to be 20±1 μM. After 12 hr particle
exposure, the EC50 value was decreased to 11±4 μM. For 24 hr exposure of A549 cells to the
PS-NH2, a median cytotoxic effect at a concentration of 10±2 μM was observed, while when
cells were exposed to the PS-NH2 for 48 hrs, the EC50 value is calculated as 2.8±0.2 μM .The
degree of toxicity is inversely related to the EC5040 and thus, when all exposure times are
compared, the cytotoxicity of PS-NH2 progressively increases from 4 hr to 48 hr exposure.

Figure 1. I) Cytotoxicity of 40 nm amine-modified polystyrene nanoparticles (PS-NH2) after
4, 12, 24 and 48 hr exposures determined by the Alamar Blue assay. II) Cytotoxicity of 40
nm amine-modified polystyrene nanoparticles (PS-NH2) after 8 exposure determined by the

Alamar Blue and MTT assays. The concentrations (2.5, 5 and 10μM) which are used
throughout the study are indicated by red dashed lines. Data are expressed as % of control
mean ± SD of three independent experiments.
As an alternative and complementary measure of cytoxic response, the MTT assay was also
employed to monitor the toxic response of A549 cells to PS-NH2 exposure. Figure 1.II
compares the dose dependent responses for 8 hr PS-NH2 exposure from the two assays, MTT
and AB. EC50 values for both assays were observed similar to each other which are 13±1 and
15±5 μM for AB and MTT, respectively. Although EC50 values were calculated to be similar,
the difference in the underlying mechanism of toxicity changes according to concentration of
PS-NH2. The increasing concentrations of PS-NH2 cause a rapid decrease in cell viability
when it is determined by the AB assay, compared to that which is determined by MTT after
8hr exposure. For this reason, significantly different toxicological profiles can be obtained
from well-established cytotoxicity assays due to the limitations of specific colorimetric label
based assays.
The dose and time dependent cytotoxic response of a cytotoxicological assay reflects a
complex cascade of events, triggered by endocytosis of the nanoparticles, giving rise to
subsequent oxidative stress, inflammatory responses, apoptosis and cell death, as described
for example by Maher et al.41. Each cytotoxicity assay measures the toxic response of cells in
different ways, and the relative sensitivity of the assay depends on the events in the cascade
to which it is sensitive. AB is a measure of overall cellular activity as measured by the
transformation of Rezazurin Sodium Salt (weak fluorescence) into Resofurin Sodium salt
which has a strong fluorescence. Although the exact mechanism of the reduction reaction is
unknown, as there are multiple cellular sites of conversion, AB assay provides valuable
information about the overall activity of the cell population38,39,42,43. On the other hand, the
MTT assay measures the cell activity based on formazan product formation which relates to

the mitochondrial activity of cells44. In cases such as cellular exposure to poly (amido amine)
(PAMAM) dendrimer nanoparticles, in which endosomolysis leads to translocation of the
nanoparticles to the mitochondria, MTT is seen to be significantly more sensitive than AB,
which measures the subsequent change to the cytosolic activity45. The formation of ROS
inside the cell is regulated by different factors such as protective enzymes and antioxidant
mechanisms. The ROS formation and cell protection mechanism works through the cross-talk
between cytosolic events and mitochondrial events upon the presence of ROS. In the case of
PS-NH2 exposure, the nanoparticles are trafficked from endosomes to lysosomes, and the
toxic insult is first manifest through generation of ROS in the cytosol (around cell membrane
and lysosomes), which subsequently impacts on the mitochondria46,47.
Although cytotoxicity assays such as AB, Neutral Red, and those based on tetrazolium salts
(MTT, MTS, WST-1), provide valuable information about the toxic effect of material the
under investigation, these techniques are not a definitive measure of cell viability and provide
little information about the mechanism of action of the toxicants in terms of molecular
determinants and pathways. In contrast, as a label free technique, Raman spectroscopy can
potentially provide a high content spectroscopic profile of the cells and complete biochemical
response at a given exposure time and dose (as illustrated by the mean spectra of the
subcellular regions of the unexposed cell population, Supplementary Figure S1). The dose
dependent cytotoxicity measurements serve as a range finding test for Raman analysis.
Figure 2 shows the PCA of spectra corresponding to cytoplasm, nucleus and nucleolus of the
8hr unexposed control and 10 μM PS-NH2 exposed cells. Although this dose is less than the
EC50 for both assays at this time point, it induces a significant reduction in viability, as
registered using the AB assay (Figure 1.II). Figure 2.I shows the scatter plots of PCA and the
data sets relating to unexposed and exposed cells are indicated with closed circles and open
circles, respectively and coded with colours according to the different cellular regions.

Cytoplasm, nucleus and nucleolus are indicated with red, green and blue, respectively. The
same colour coding system is used for exposed cells, but with the use of open circles. The
spectra corresponding to the nuclear areas (nucleus and nucleolus) and cytoplasm are clearly
differentiated for both exposed and unexposed cells according to PC1, which represents the
most significant variance (46%) among the data, originating from biochemical differences
between the combined nuclear area and cytoplasm. The spectra relating to the cytoplasm of
both exposed and unexposed cells score negatively according to Loading 1 (PC1<0), while
nuclear and nucleolar spectra score positively according to Loading 1 (PC1≥0). PC2 gives
information about the second highest variance (16%) among the data sets, and differentiates
each region for exposed and unexposed cells. For all cellular regions, exposed cells are
clearly differentiated from unexposed cells, indicating that the spectral differences are larger
than the intrinsic variability of each region, and score positively according to PC2 (indicated
by open circles) while unexposed cells score negatively (PC2<0) (indicated by closed
circles).

Figure 2. I) Scatter plot of the PCA of spectra corresponding to cytoplasm, nucleus and
nucleolus of the (8hr) unexposed and PS-NH2 exposed cells for 10 μM concentration of
nanoparticles. Different cellular regions are coded as follows; red for cytoplasm, green for
nucleus and blue for nucleolus. Exposed and unexposed cells are indicated by open circles

and closed circles, respectively. II) First 2 loadings of PC analysis; loadings are offset for
clarity and the dotted line represents the zero ‘0’ point for each loading. In loading 1, notable
bands which are used to differentiate the nuclear region from cytoplasm are indicated by
black dashed outlines.
Figure 2.II shows the first two loadings of the PCA, corresponding to all regions of exposed
and unexposed cells. As seen in Figure 2.I, exposed and unexposed cells differentiate from
each other based on the differences in biochemical composition of nuclear regions and
cytoplasm according to PC1. The spectra of the nuclear area of the cell, which is composed of
nucleus and nucleolus, score positively, while spectra corresponding to cytoplasm score
negatively, according to PC1, for both exposed and unexposed cells. For this reason, the
positive features of loading 1 are dominated by nuclear and nucleolar related bands, while
negative features relate to the cytoplasm. The most dominant features which are used to
differentiate the nuclear area (nucleus and nucleolus) and cytoplasm, the positive features at
785, 1003, 1094 cm-1 and the negative features ~ 719, 1437 cm-1, are indicated with black
outlines in Figure 2.II. Amongst the positive features, the bands at ~ 785 cm-1 (Nucleic acids
uracil (U), thymine (T), cytosine(C) ring breathing modes in the DNA/RNA bases, O-P-O

backbone), 1003 (phenylalanine(Phe)), 1094 cm-1 (DNA), 1248 cm-1 (Guanine(G) and
cytosine (NH2), Amide III), 1339 cm-1 (Phe, tyrosine(Tyr), nucleic acid), 1373 cm-1 T, G,
adenine(A) bases of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA)), 1575 cm-1
(G, A of nucleic acids) and 1678 cm-1 (bound or free NAHD, Amide I region) indicate the
predominance of nucleic acids and proteins which are abundant in the nuclear area48-50. On
the other hand, the dominant negative features include those at ~719 cm-1 (membrane
phospholipid head, phosphatidylcholine), 873 cm-1 (hydroxyproline, tryptophan (Trp)), 1064
cm-1 (acyl chains, (C-C)), 1078 cm-1 (phospholipids), 1298 cm-1 (fatty acids) and 1437 cm-1
(Lipids, acyl chains, CH2 deformation), which are more characteristic of the lipid rich

cytoplasm. Unexposed and exposed cells are differentiated mainly according to loading 2, as
seen in Figure 2.II. Although there are some contributions to the loading 2 from PS-NH2 in
the positive features, cells exposed for 8 hr to 10 μM of PS-NH2 are mainly differentiated
from the unexposed cells by increases in the intensities of nucleic acid bands at 785 cm-1 and
810 cm-1 (RNA, O-P-O stretching) cm-1 and protein Amide I band at 1604 cm-1. For loading
2, the bands derived from PS-NH2 at 620, 1003, 1030 and 1600 cm-1 have been excluded
from discussion.
Polystyrene nanoparticles are taken into the cells by the mechanism known as endocytosis.
Previous studies have confirmed that the polystyrene nanoparticles (PS-COOH) are taken up
into endosomes and carried to lysosomes15,26,51-53. Most of the nanoparticles are observed in
lysosomes after 8 hr particle exposure. For this reason, after shorter exposure times, for
example 8 hr, most of the cytotoxic responses can be attributed to changes in the cytoplasm
and due to a cascade of processes including ROS formation, mitochondrial damage and
lipidosis26,41, but notably, the nucleus and nucleolus are not affected as much as cytoplasm. In
order to better identify changes in the biomolecular composition of the cytoplasm, nucleus
and nucleolus upon PS-NH2 exposure, the mean spectra of particle exposed cells and
unexposed cells were obtained and the spectral differences for each individual cellular region
are evaluated by subtracting the mean spectra of exposed cells from the mean spectra of
unexposed cells (Figure 3). When the mean spectra of cytoplasm, nucleus and nucleolus are
analysed, the most significant changes are observed in the cytoplasm (red) of exposed cells
compared to the corresponding control, as seen in Figure 3. For all cellular regions, some
contributions from the PS-NH2 are observed in PS-NH2 exposed cells and the bands related to
PS are highlighted with grey and excluded from band assignments.

Figure 3. Mean difference spectra of cytoplasm (red), nucleus (green) and nucleolus (blue)
obtained by subtraction of mean spectra of 8hr PS-NH2 exposed cells from mean spectra of
unexposed cells. The spectra are offset for clarity, the dashed line indicating the zero point.
The bands related to PS are indicated with grey highlights.
Cellular events as a result of nanoparticle exposure to, and uptake of, a toxicant cause the
production, consumption and/or damage of biochemical constituents inside the cells. The
changes in the biochemical constituents are reflected in the Raman spectral data sets and can
be used to identify different cellular events. When cells are exposed to 10 μM PS-NH2 for 8
hr, the most significant changes are observed in the cytoplasm, as seen in Figure 3. The
intensity of the bands at 785 and 810 cm-1 become significantly higher compared to the
controls. The band at 785 cm-1 can be attributed to the ring breathing mode of nucleic acid
bases (U, T and C) or O-P-O backbone stretching of nucleic acids, as so can be attributed to
either RNA or DNA46-48. The band at 810 cm-1 is attributed to RNA structures54,55 and relates

to asymmetric stretching of the sugar-phosphate diester. The presence of 785 and 810 cm-1
bands in Raman spectra of the cytoplasm has been examined in the study of Ghita et al.56,
which showed that an increase of the RNA bands during cell differentiation can be attributed
to repressed translation of mRNAs and increasing amounts of noncoding RNAs in the
cytoplasm. As seen in Figure 3, upon PS-NH2 exposure, the band at 810 cm-1 shows a
significant increase compared to its control with a concomitant increase in the band at 785
cm-1, while control cells did not show any significant band at 810 cm-1 for cytoplasm
(Supplementary Figure S2).
The exposure of cells to toxic PS-NH2 is known to result in ROS formation57. Increased ROS
levels in the cell first impacts on the mitochondria and causes the mediation of cytotoxic
effects and release of pro-apoptotic factors with increasing production of mitochondrial
ROS58, which in turn can cause deformation of cytoplasmic RNAs which generally localises
in close proximity to the mitochondria and results in repression of translation and
accumulation of noncoding RNAs in the cytoplasm of exposed cells. The role of oxidative
stress in the repression of mRNA translation has been shown previously59-61. For this reason,
an increase in the intensity of the 810 cm-1 band in the cytoplasm can be attributed to changes
in RNA content, as a result of oxidative stress and can be used as a mitochondrial damage
marker in a label-free way. Although the band at 785 cm-1 can be attributed to either DNA or
RNA, the concomitant increase in the 810 cm-1 for short exposure times is consistent with a
primary attribution of increased RNA accumulation in cytoplasm.
The cytoplasmic responses upon particle exposure are further explored according to their
correlation with the concentration of toxicant. The effect of PS-NH2 exposure on A549 cells
was also monitored using intermediate (5M) and sub-lethal doses (2.5M), for 8hrs. PCA
clearly differentiates unexposed and exposed cells according to PC1 for all exposure doses.

Scatter plots of unexposed and exposed cells for each exposure dose are provided in
Supplementary Figure S3, and a representative example of scatter plot of cytoplasm of
exposed and unexposed cells for 10 μM PS-NH2 is shown in Figure 4.I. The respective
loadings for the cytoplasmic regions of 2.5, 5 and 10 μM are shown in Figure 4.II.
For 10 μM PS-NH2, which is close to the EC50 value for AB, exposed cells are differentiated
from unexposed cells due to a significant increase of the intensity of nucleic acid bands
represented by positive features of loading 1 (785 and 810 cm-1), which can also be seen in
the difference of mean spectra of exposed and unexposed cells (Figure 3). Notably, the
changes in this region are seen to evolve monotonically with exposure dose (Figure 4, Figure
S4), confirming a direct correlation between the changes in nucleic acid spectral signatures
and particle exposure.

Figure 4. I) Scatter plot of the PCA of spectra corresponding to cytoplasm of the unexposed
cells (closed circles) and cells exposed to 10 μM PS-NH2 for 8 hr (open diamond). II)
Loadings of PC1 for pairwise analysis of cytoplasm of exposed cells with the control for 10
μM (red), 5 μM (blue) and 2.5 μM (black) for 8 hr. The dotted line represents the zero ‘0’
point for each loading. Loadings are offset for clarity.

Negative features of the loading (unexposed cells) are observed to be richer in protein and
lipid content (bands at 1062, 1080, 1270, 1299 and 1438 cm-1). The relatively higher amount
of the lipids in unexposed cells compared to PS-NH2 exposed cells can be attributed to
damage of the lipidic structures such as lysosomes and membrane bounded cellular
compartments upon PS-NH2 exposure. When the nanoparticles are localised inside the
lysosomes after 8 hrs, they become trapped due to the protonation of their surface in low
lysosomal pH (~4.5). Protonation and the change in the lysosomal pH cause formation of a
gradient for lipids to traffic into the lysosomes from the cytosol and finally the formation of
enzymatically unbreakable complexes (Myeloid bodies)26. The lipid transfer from cytoplasm
to lysosomes and accumulation of lipids in lysosomes, a phenomenon known as lipidosis,
causes the loss of lipid related bands in the spectral profile of the cytoplasm. Moreover, later
stages of lipidosis cause a distortion and rupture of the lysosomal membrane 62-65. Therefore,
changes in the intensities of the bands at 719 cm-1 (membrane phospholipids), 1270-1301 cm1

(phospholipids, lipids), 1437 cm-1 (acyl chain of lipids) can be used to track lysosomal

damage during nanotoxicological screening of toxic nanoparticles.
As seen in Figure 4, with the exception of the monotonic increase in the nucleic acid related
bands at 785 and 810 cm-1, sub lethal doses of PS-NH2, result in significantly different
spectral profiles compared to the cells exposed to 10 μM PS-NH2. When the concentration of
PS-NH2 was reduced to 5 μM, the exposed cells show increased amounts of lipid, protein and
nucleic acid in the cytoplasm compared to unexposed cells (the positive features of loading
1). Also, nucleic acid related bands are prominent at around 1095 cm-1 (PO2-), 1177 cm-1 (C,
G) and 1292 cm-1 (C) , but are not evident in the 10 M PS-NH2 exposed cells. The 5 μM PSNH2 exposed cells also show increases in the intensity of protein (1030, 1208, 1250 and 1654
cm-1) and lipid bands (1064 cm-1), compared to unexposed cells. A similar PC Loading
profile was observed when the dose was reduced to 2.5 μM, exhibiting a decrease in the

intensities of the bands at 785 cm-1 (Nucleic acids), 810 cm-1 (RNA), 1127 cm-1 ((C-N)),
1266 cm-1 (Amide III (α-helix)), 1319 cm-1 (G), 1333 cm-1 (G) and an increase in the
intensity of the band at 1655 cm-1 (Amide I). When the respective loadings for each dose are
compared, lipid and protein related bands are inverted in going from lethal (10 μM) to sub
lethal (2.5 μM) PS-NH2 doses. The change in the amount of lipid and protein structures with
increasing dose can be related to damage of protein and lipid structures as a result of
increasing amount of ROS inside the cell for toxic exposures.
Following the effect of dose of PS-NH2 on A549 cells, the effect of exposure time was
monitored by comparing particle exposed cells with their controls. In order to evaluate
spectral differences progressively as a function of time, a sub lethal dose of PS-NH2 (2.5 μM)
was chosen and cells were exposed to the nanoparticles from 4 to 48 hrs. Figure 5.I shows the
scatter plots of the PCA of spectra corresponding to cytoplasm of exposed and unexposed
cells for 24 hr (2.5 μM), as a representative example of separation between exposed and
unexposed cells. Scatter plots of cytoplasm of exposed and unexposed cells for each exposure
time are provided in Supplementary Figure S5. As seen in Figure 5.I, for the case of 24 hr,
exposed and unexposed cells are largely differentiated according to PC1 (Explained Variance
45%). Figure 5.II shows the comparison of the loadings of PC1 of cytoplasm of exposed and
unexposed cells for 4, 8, 12, 24 and 48 hrs.

Figure 5. I) Scatter plot of the PCA of spectra corresponding to cytoplasm of the unexposed
cells (close circles) and PS-NH2 exposed cells (2.5 μM) (open circles) for 4, 8, 12 and 24 hr,
II) Comparison of the Loading of PC1s for different PS-NH2 concentrations (cytoplasm). 4,
8, 12, 24 and 48 hr are indicated with black, blue, green and magenta red, respectively.
Positive features of the PCs are related to exposed cells while negative features of the PCs are

related to their controls. Loadings are offset for clarity. The dotted line represents the zero ‘0’
point for each loading.
As in the case of the exposure dose dependent spectral profiles, the evolution of the nucleic
acid features at 780 cm-1 and 810 cm-1 is observed to be prominent. However, these features
are weak after 4 hr PS-NH2 exposure, and the particle exposed cells differentiate from the
unexposed cells largely due to their protein and lipid content. The bands at 1003 cm-1 (Phe),
1602 cm-1 (Phe) and 1640 cm-1 (Amide I) can be attributed to damaged protein structures
resulting from the damage in the mRNA template and the distorted proteins accumulate
inside the cell as well as normal proteins due to lysosomal damage51. The increasing intensity
of the lipid bands at 1298 and 1440 cm-1 indicates an increasing amount of lipids in the
cytoplasm due to increasing amount of endosomes and lysosomes upon PS-NH2 exposure.
When the time of exposure of the cells to the PS-NH2 is increased to 8 hr, following the
increases in protein and lipid bands, some changes start to occur in RNA accumulation in the
cytoplasm due to the onset of repression of mRNA translation, which are manifest in the
Raman spectra of PS-NH2 exposed cells (positive features of loading 1) as an increase in the
band at 810 cm-1. An increase in the intensity of bands at 1319 (G) cm-1 and 1333 (G) cm-1
can also be observed with increasing exposure time. For this exposure time, the sharp band at
1602 cm-1(Phe) disappears and the intensity of the 1003 cm-1 band reduces, which can be
attributed to the onset of degradation of proteins.
After 12 hr exposure of A549 cells to PS-NH2, more significant changes occur in the
biochemical composition of particle exposed cells compared to previous exposure times. For
this exposure time, as seen in Figure 5.II, the nucleic acid band at 785 cm-1 shows an increase
in its intensity which indicates the increasing amount of nucleic acids in cytoplasm. Similar
to the effect of dose, in the case of increased exposure time, the increase of nucleic acids in
the cytoplasm can be observed at 810 cm-1 (RNA), with a larger increase in 785 cm-1 (RNA

and DNA) compared to 8 hr exposure. Although the increase in the 785 cm-1 band was
attributed to RNA accumulation for shorter exposure times (up to 8 hr), an independent
increase is observed on the 785 cm-1 band compared to 810 cm-1 with increasing exposure
time, which can be attributed to an increase of DNA content in the cytoplasm. The increasing
amount of DNA in the cytoplasm can be attributed to the decay of mitochondrial membrane
and release of mitochondrial DNA into the cytoplasm, at this time point. ROS formation and
mitochondrial decay affect the spectral profile of proteins and lipids in particle exposed cells
and this is reflected in the Raman spectra of unexposed cells and causes the appearance of the
bands at 1200-1300 cm-1 (Amide III) and 1438 cm-1 (Protein, Lipids) as negative features of
PC1, which represent the unexposed cells. Also notable is the emergence in the loadings
spectrum of bands at 1299 and 1438 cm-1. They are both associated with lipid content inside
the cytoplasm and the change in the intensity of the bands can be attributed to damage of
lipidic structures due to lipidosis after PS-NH2 exposure. The intensity changes in the 1438
cm-1 band can be further used determine cytotoxic events in the cytosol and damage of
lysosomes. The band at 1299 cm-1 is progressively reduced until 12 hour particle exposure
and becomes inverted for 24 and 48 hr particle exposure, which indicates that lipids are more
abundant in unexposed cells compared to exposed ones. The intensity of the band at 1438
cm1 did not show any change up to 8 hr, but this band is inverted with increasing intensity
from 12 to 48 hr, such that it becomes a dominant feature of the discriminating loading.
Moreover, the intensity of the 1003 cm-1 (Phe) band reduces significantly, while there is a
clear broadening of the Amide I band (1550-1700 cm-1). The intensities of the nucleic acid
(785 cm-1) and RNA (810cm-1) bands increase further for 24 hr exposure, while the protein
and lipid bands (1266, 1299 and 1438 cm-1) become more significant as negative features
(unexposed cells) of PC1. The further increase in the intensity of the band at 785 cm-1 can be
attributed to disruption of membrane structures and release of DNA into the cytoplasm66.

When cells were exposed to PS-NH2 for 48 hrs, the exposed cells are differentiated from
unexposed cells according to their nucleic acid content, as the bands at 785 and 810 cm-1 are
observed in the positive features of the loading 1. The band at 1003 cm-1, which indicates the
presence of Phe, becomes inverted for the 48 hr exposure. Moreover, the bands at 1299 and
1438 cm-1 become dominant in the negative features of the loading 1. The change in the lipid
bands can be attributed to further decomposition of lipid structures in cell upon longer
exposure. Also, the band at 1268 cm-1 appears for this exposure time in the negative features,
which indicates a change in the conformational structures of the proteins. The contribution of
the Amide I band at 1658 cm-1 has become inverted following 48 hr particle exposure. The
inverted bands on loading 1 of PC can be attributed to less abundance of proteins and lipids
in particle exposed cells.
The spectra of the cytoplasm of PS-NH2 exposed cells are mainly differentiated from
unexposed cells by the intensities of the bands at 785 and 810 cm-1. Moreover, another
significant change is observed in the Amide I region of proteins, with increasing exposure
time. In order to monitor spectral changes in the Amide I region, the Amide I band (15501700 cm-1) was analysed separately in detail. Oxidative stress in a cell causes damage in
protein structures and changes the protein secondary structure and tertiary conformation. The
changes in protein conformations are reflected in the Amide I region of the Raman spectrum.
With increasing exposure time, a broadening and shift is observed in the Amide I band. The
Amide I band represents the different secondary structures of the proteins, such as α-helix, ßsheet, loops67, and the broadening or shift in Amide I band can be attributed to a change in
secondary structure of proteins as a result of oxidative stress.
The Amide I region of proteins in the cytoplasm of PS-NH2 exposed cells and changes in the
bands upon particle exposure are detailed in Figure 6 and Table 1, for different exposure
times (I-V) from 4 to 48 hr. The loadings of PC1 of cytoplasm of unexposed and exposed

cells were used and peak fitting was carried out for all exposure times, using LabSpec
Software. As seen in Figure 6, the band at 1602 cm-1, which indicates the presence of Phe, is
observed for all exposure times, and a change in the total area of the band is observed as a
function of time. The band area increases from 0.51 to 1.88, from 4 to 12 hr exposure, but
then decreases to 0.34 for 24 hr exposure. Following 48 hr exposure, this band has totally
disappeared from the positive features of loading 1. For the first 4 hr particle exposure, both
α-helix and ß-sheet structures of protein are observed. However, with increasing exposure
time, α-helix structures become dominant and the bands related to the presence of ß-sheet
structure disappear (1674 and 1679 cm-1). Thus, with increasing exposure, the Amide I band
becomes dominated by α-helix bands, resulting in an apparent shift to lower wavenumbers up
to 24 hr exposure. When cells are exposed to the PS-NH2 for 48 hrs, the Amide I band
becomes completely inverted and a sharp band at 1658 cm-1(Amide I, α-helix) is observed in
the negative features of the loading 1 48-50.

Figure 6. Comparison of the changes in the Amide I region of loading 1 for 4 (I), 8 (II), 12
(III), 24 (IV) and 48 (V) hrs. The loadings and sum of the bands after fitting are indicated

with blue and red lines, respectively. Each individual fitted band is represented by black
lines. Peak positions are indicated on the top of the fitted figures.

Table 1. Assignments of Raman Bands of proteins in Amide I Region47-49,68.

Band Positions (1550-1700
cm-1)

Band Assignments

1602

Phe

1618

Trp, Tyr ((C=C) stretch.)
Amide I
(Both α-helix and ß sheet)
Amide I
(α-helix)

1634
4 hour

PS-NH2 Exposed Cells

1645

8 hour

1679

Amide I
(ß sheet)

1602

Phe

1655
1569
12 hour

1602
1625
1647
1669

24 hour

1582
1602
1625
1645
1669
1685

48 hr

1658

Amide I
(α-helix)
Trp
(Indole Ring)
Phe
Trp
Random coils
Amide I
(α-helix)
Phe
Phe
Trp
α-helix
Amide I (C=O)
Amide I (disordered structure; non
hydrogen
bonded)
Amide I (inverted)

Time and dose dependent cytotoxicity can be seen as a 3D response surface rather than a 2D
curve, due to the variance of molecular determinants forming overall cytotoxicity41. Thus,
sublethal concentrations can elicit a similar effect to higher concentrations at different
timepoints. Figure 7 shows the comparison of loading 1 of PC of cytoplasm of unexposed and
exposed cells for cytoplasm for 8hr exposure 10 μM and 48hr exposure 2.5 μM PS-NH2.
Both loadings show similar positive (exposed cells) and negative features (unexposed cells),
with the possible exception of the band at 810 cm-1 which indicates the presence of
accumulated noncoding RNA in the cytoplasm. This difference can be explained by the more
acute toxic effect of repression of translation of mRNA of higher exposure doses. More
molecular determinants of toxicity are manifest for the nucleic acid constituents for all
exposure times, although more prominantly for high doses and long exposure times. For this
reason, the difference in the bands related to nucleic acids can be attributed to changing
amounts of molecular determinants. Compared to their controls, exposed cells showed lower
contributions of protein and lipids, which can be attributed to damage to these biochemical
constituents in particle exposed cells due to oxidative attack.

Figure 7. Comparison of the Loading 1 of PCs of cytoplasm for exposed and unexposed cells
after 8hr exposure to 10 μM (red) and 48hr 2.5 μM (blue) PS-NH2. Positive and negative
features of the loadings relate to exposed and unexposed cells, relatively. The significant
differences between the loadings are indicated with black circles. Loadings are offset for
clarity. The dotted line represents the zero ‘0’ point for each loading.
As shown in Figure 2, comparatively fewer changes are observable in the spectral signature
of the nucleus and nucleolus, as might be expected, given the uptake and trafficking of the
PS-NH2 is through the cytoplasm, over a period of up to 24 hrs. No localisation of PS-HN2
nanoparticles in the nucleus has been reported and, indeed, it has been seen that neutral PS
nanopatricles are stored in lysosomal vesicles over several passages of the cells33,69.
Nevertheless, as shown in Figure 8, the mean difference spectrum of the nuclear region does
show indications of reduced contributions of nucleic acids at 785 and 810 cm-1, after 24 hr

exposure, consistent with leakage of nuclear material into the cytoplasm after the onset of
apoptosis. This is also consistent with the larger increase of nucleic acid features in
cytoplasm of PS-NH2 exposed cells after 24 hr exposure (Figure 5.II).

Figure 8. Difference spectrum of nucleus of PS-NH2 exposed cells and unexposed cells
obtained by subtraction of mean spectra of 24 hr PS-NH2 exposed cells from mean spectra of
unexposed cells.
In the case of exposure to the PS-NH2, the most significant changes are observed in the
cytoplasm, as expected due to the uptake mechanism and cellular trafficking of the PSNH2.
The uptake mechanism by endocytosis and subsequent cellular trafficking initiates a series of
molecular events and hence molecular determinants of the cytotoxicity. In endocytosis, toxic
PS-NH2 particles are carried to lysosomes by endosomes resulting in lipidosis, lysosomal
membrane rupture and ROS in the cytosolic region. The mitochondria of the particle exposed
cells are affected as a result of cytosolic changes and mediate the release of pro-inflammatory
factors as signals of cytotoxicity. On the other hand, for example doxorubicin, commonly

used anti-cancer chemotherapy drug, is taken into cells by passive diffusion and targets the
nuclear region directly. The cytotoxic effects are manifest initially in the nuclear and
nucleolar regions of the cell, and only later in the cytoplasm16. The process is inverse for PSNH2, whereby the toxic effects of the particles are initially seen in the cytoplasmic region for
shorter exposure times, although changes in the nuclear area may be more significant in
chronic exposures, and linked with genotoxic effects.
In this study, the cytoplasmic changes relating to molecular events upon particle exposure
due to the uptake mechanism and cellular trafficking the PS-NH2, have been evaluated in a
dose and time dependent manner, using Raman spectroscopy. The established initial response
of oxidative stress is not evident in the spectral response, however. ROS such as hydrogen
peroxide (H2O2), superoxide anion (

.

) and hydroxyl radicals (HO ) are known to be Raman

inactive and, in addition, they are consumed rapidly after initial generation46,70. Nevertheless,
although the molecular signatures of ROS are not possible to identify with Raman
spectroscopy, the signatures of the resultant oxidative stress can be monitored via the
signatures of the changes in biochemical constituent of the cells. Oxidative stress in the
cytoplasm triggers a complex cascade of events which can include mitochondrial membrane
potential decay, caspase activation, apoptosis and ultimately cell death. For a more extensive
discussion of the responses, see for example references 29 and 41. The Raman spectral
biomarkers of ROS formation, lysosomal damage and biochemical composition changes
upon nanoparticle exposure are identified and the most dominant features changing inside the
cytoplasm of the cells upon particle exposure are determined to be the bands at 785 and 810
cm-1 which can be attributed to nucleic acids inside the cytosol. It is notable, however, that
the spectral changes are dominated by the 785 and 810 cm-1 bands, rather that the whole
spectrum of RNA or DNA71, suggesting that the spectral signature is due to conformational
changes in the nucleic acid structures due to change in the environment rather than

production or consumption of the nucleic material. Especially for sub-lethal doses of PS-NH2,
some contributions are observed to the spectra of cells which indicate a higher protein content
compared to control cells. Cells use a recovery mechanism to stabilize the increased ROS
levels inside the cells upon exposure to a toxicant46. Increased production of enzymes such as
superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, causes an
increase in protein related bands. For this reason, the changes in cytosolic acids followed by
increased protein profile can be attributed to increased ROS levels and the Raman profile can
be used as a Nanotoxicological assay biomarker for a wide variety of nanomaterials.
In comparison with the responses of the classical cytotoxic assays, (Figure 1.II), significant
spectral changes are observed over a dose range (from 2.5 to 10 μM), in which MTT shows
no change, but AB shows significant change. These spectroscopic changes are therefore
better correlated with AB, consistent with an interpretation of origin in cytosolic RNA which
subsequently accumulates around the mitochondria. The changes in 1299 and 1438 cm-1
bands, which are associated with the later stage toxic response and become inverted after 12
hr particle exposure with an increasing intensity in the negative features of the loading 1, may
be better correlated with the MTT response and therefore mitochondrial decay (Figure 5.2).
Mitochondrial ROS production can cause significant oxidative stress, damaging protein and
lipid structures and mediating the release of factors to initiate the apoptotic process.
Spectral changes, as elucidated by PCA, are complex combinations of contributions of the
multitude of biomolecules involved in the cellular responses. However, the combination
signature shows consistency in its evolution as a function of time and dose, and correlates
well with the known cytotoxic responses. Therefore, not individual spectra, but signatures at
785 cm-1 (either RNA or DNA), 810 cm-1 (RNA), 1299 cm-1 (lipids) and 1435 cm-1 (lipids)
and proteins Amide I (1550-1700 cm-1) region can be a guide to nanotoxicological screening.

Conclusion
Classical colorometric cytotoxicological assays monitor a single endpoint by which the
cellular response to a toxicant is quantified in terms of the IC50. The response is, however, a
complex cascade of events, and different assays can report significantly different viability
results, and yield little information about the mechanisms of response. The use of a label-free
and rapid technique which provides multiparametric information about the changes in the
biomolecular structures such as proteins, lipids and nucleic acids following exposure to a
toxicant can accelerate the toxicological screening of nanomaterials. This study has identified
spectral signatures which are correlated with nanoparticle exposure dose and time, and
therefore the known mechanisms of cellular response and toxicity, demonstrating the
potential of Raman spectroscopy as a label-free technique to provide multi-parametric
information about the biomolecular changes upon a toxicant exposure. It is demonstrated that
spectral profiles of the particle exposed cells can be used to track the fingerprint of the
molecular responses. Time and dose dependent cytotoxic responses and their reflection to the
biochemical fingerprint of the cells can be monitored by using Raman spectroscopy in a
progressive way. For all exposure times and doses, the most prominent Raman spectral
marker, reflecting the cytotoxic response to exposure to model PS-NH2 nanoparticles, is
found to be the bands at 785 and 810 cm-1 in the cytoplasm, reflecting changes in cytoplasmic
nucleic acid content. Notably, this response is not normally identified by conventional
cytotoxicity assays. The concomitant and subsequent changes in the intensity of the bands
corresponding to proteins (Amide I region (1550-1700 cm-1) and lipids (1229 and 1438 cm-1)
can also be used to determine toxic effect of nanoparticles. The use of Raman spectroscopy
helps to corroborate and further elucidate the mechanism of action of the nanoparticles within

cells and Raman cytotoxicity spectral-markers identified for model nanoparticles can
potentially be used to screen for the mode of action and degree of toxicity of novel
nanoparticles, in a single label-free assay.
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